Diffuse Large B-Cell Lymphoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Diffuse Large B-Cell Lymphoma
Dec 20, 2024, 18:00 | Science
Real-world data on the clinical features, therapy patterns, and outcomes of older adults with diffuse large B-cell lymphoma in Latin America
Cancer and Aging Research Group shared a study by Myrna Candelaria et al. on X:…
Dec 20, 2024, 10:22 | Insight
Jame Abraham: Glotiftamab combination shows safety and efficacy for relapsed large B-cell lymphoma
Jame Abraham,Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic, shared a…
Nov 14, 2024, 12:33 | Insight
Ajay Major: Liso-cel in DLBCL with secondary CNS diagnosis by Jennifer Crombie
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…
Oct 14, 2024, 16:46 | Blog
Raul Cordoba: End points in clinical trials in diffuse large B-cell lymphoma
Raul Cordoba shared on X: "Hematology End points in clinical trials in diffuse large B-cell…
Aug 23, 2024, 14:13 | Insight
Oncology Brothers: Discussions around the algorithm for DLBCL
Oncology Brothers shared on X: "This is the algorithm we have used during our discussion…
Jul 29, 2024, 13:35 | Insight
Megan Melody: Cellular therapy and bispecific antibodies for large B-cell lymphoma
Kate Cwynarski, Haematogist-Oncologist in Lymphoma and CLL at University College London Hospital, shared a post on…
Jun 19, 2024, 04:44 | Cancer Types
Diffuse Large B-Cell Lymphoma: What patients should know about
What is diffuse large B-cell lymphoma? Diffuse large B-cell lymphoma (DLBCL) is an aggressive (fast-growing)…
Apr 29, 2024, 17:36 | Blog
Kate Cwynarski: Fantastic talk by Marco Ruella on CAR-T
Kate Cwynarski, Consultant Haematologist at University College London Hospitals NHS Foundation Trust, recently shared on…
Jan 19, 2024, 18:00 | Blog
Prashant Mehta: My thoughts on developments in DLBCL management
Prashant Mehta, Senior Consultant and Assistant Professor in the Department of Medical Oncology/Hematology-oncology and Bone…
Dec 8, 2023, 12:40 | Insight
Amar Kelkar: We hope putting out independent cost-effectiveness analyses like this will encourage others to join
Amar Kelkar, Physician at the Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard…
All: 10 Posts: 1 - 100
Special Coverage